Izotropic Corporation | News
7/15/2025
Izotropic Prepares New Platforms to Educate and Engage

6/13/2025
Izotropic Provides Marketing Update

6/10/2025
Izotropic Updates License Agreement Terms with University of California

5/16/2025
Izotropic’s U.S. FDA Regulatory Pathway Greenlit, Company Provides Corporate Update

4/2/2025
Izotropic Engages International Communications Consultant, Grants Incentive Stock Options & RSUs to Key Personnel, Amends Promissory Note with Primary Lender

3/25/2025
Izotropic Completes Pre-Submission Meeting with FDA for Breast Cancer Screening Indication

3/10/2025
Izotropic to Present at Investor Conference March 13th

2/19/2025
FDA Sets Meeting Date with Izotropic

2/14/2025
Izotropic Closes Non-Brokered Private Placement

2/7/2025
Izotropic Announces Non-Brokered Private Placement- February 2025

1/29/2025
Izotropic Announces Timelines and Milestones to IzoView Product Launch

1/17/2025
Izotropic Featured in Announcement of Research and Markets’ U.S. Breast Cancer Analysis and Forecast

1/15/2025
Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions

1/9/2025
Izotropic Files Pre-Submission with U.S. FDA for Breast Cancer Screening